Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface
- PMID: 11807225
- DOI: 10.1099/0022-1317-83-2-323
Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface
Abstract
A vaccinia virus (VV) recombinant is described in which the outer envelope of extracellular enveloped virus (EEV), cell-associated enveloped virus (CEV) and intracellular enveloped virus (IEV) is labelled with the enhanced green fluorescent protein (EGFP) derived from Aequorea victoria. To construct this virus, EGFP was fused to the VV B5R protein from which the four short consensus repeats (SCRs) of the extracellular domain had been deleted. Cells infected with the recombinant virus expressed a B5R-EGFP fusion protein of 40 kDa that was present on IEV, CEV and EEV, but was absent from IMV. The recombinant virus produced 2- and 3-fold reduced levels of IMV and EEV, respectively. Analysis of infected cells by confocal microscopy showed that actin tail formation by the mutant virus was reduced by 86% compared to wild-type (WT). The virus formed a small plaque compared to WT, consistent with a role for actin tails in promoting cell-to-cell spread of virus. However, the enveloped virions were still transported to the cell surface, confirming that this process is independent of actin tail formation. Lastly, we compared the mutant virus with a recombinant VV in which the B5R SCR domains were deleted and show that, contrary to a previous report, the plaque size of the latter virus was reduced compared to WT. This observation reconciles an inconsistency in the field and confirms that viruses deficient in formation of actin tails form small plaques.
Similar articles
-
Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.J Virol. 1998 Jan;72(1):294-302. doi: 10.1128/JVI.72.1.294-302.1998. J Virol. 1998. PMID: 9420227 Free PMC article.
-
A mutational analysis of the vaccinia virus B5R protein.J Gen Virol. 2001 May;82(Pt 5):1199-1213. doi: 10.1099/0022-1317-82-5-1199. J Gen Virol. 2001. PMID: 11297695
-
The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.J Virol. 1998 Mar;72(3):2429-38. doi: 10.1128/JVI.72.3.2429-2438.1998. J Virol. 1998. PMID: 9499104 Free PMC article.
-
The formation and function of extracellular enveloped vaccinia virus.J Gen Virol. 2002 Dec;83(Pt 12):2915-2931. doi: 10.1099/0022-1317-83-12-2915. J Gen Virol. 2002. PMID: 12466468 Review.
-
The exit of vaccinia virus from infected cells.Virus Res. 2004 Dec;106(2):189-97. doi: 10.1016/j.virusres.2004.08.015. Virus Res. 2004. PMID: 15567497 Review.
Cited by
-
Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins.J Virol. 2003 Apr;77(7):4113-26. doi: 10.1128/jvi.77.7.4113-4126.2003. J Virol. 2003. PMID: 12634370 Free PMC article.
-
Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review.Viruses. 2017 Nov 7;9(11):331. doi: 10.3390/v9110331. Viruses. 2017. PMID: 29112165 Free PMC article. Review.
-
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.J Virol. 2005 May;79(10):6260-71. doi: 10.1128/JVI.79.10.6260-6271.2005. J Virol. 2005. PMID: 15858010 Free PMC article.
-
Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function.Mol Ther Oncolytics. 2019 May 21;14:159-171. doi: 10.1016/j.omto.2019.05.003. eCollection 2019 Sep 27. Mol Ther Oncolytics. 2019. PMID: 31236440 Free PMC article.
-
Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells.J Virol. 2003 Oct;77(19):10606-22. doi: 10.1128/jvi.77.19.10606-10622.2003. J Virol. 2003. PMID: 12970445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources